BMP6 and ocular melanoma: While BMP6 treatment (p < 0.05) and time point (p < 0.0001) were significant factors in the sGAG released into media samples, the secreted sGAG measured at a given week was only significantly different between control OM and BMP6-treated samples at 2 weeks (p < 0.05), and no sGAG was detected in 5- and 6-week samples (Fig. 5E; n = 3).